Monday, 2 March 2015

FDA rejects Pacira's application for expanded use of pain drug

(Reuters) - The U.S. Food and Drug Administration rejected Pacira Pharmaceuticals Inc's application for expanding the use of its pain drug, exparel.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)